Final ID: 063
Ip James, Noseworthy Peter, Piccini Jonathan P., Pokorney Sean, Singh Narendra, Stambler Bruce, Bharucha David, Camm Alan
Angiotensin II vascular abnormalities in 32.5% of 3322 patients with essential hypertension(EH): Use of angiotensin II analogue, saralasin.Anderson Gunnar